News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
“Slow Pay, Low Pay or No Pay”
Blue Cross Louisiana OK’d mastectomies and breast reconstructions for women with cancer but refused to pay a hospital’s full bills. For some claims, it paid nothing. This investigation has led to actors and advocates to bring stories like this one to life, which can be viewed here
‘Ghost network’ of US healthcare providers amounts to fraud, lawsuit says
Class action finds ‘staggering’ cases of people struggling to find mental health care coinciding with mental health crisis
Legalized Racketeering? How PBMs Skirt the Law to Rake in Billions
Pharmacy Benefit Managers (PBMs) have been under scrutiny lately for their actions as middlemen in the flow of prescription drugs from manufacturers to patients. But perhaps their worst actions are buried within a maze of consolidation and paperwork. Big Insurance has consolidated the entire pharmaceutical benefit, claim, and dispensing sector to squeeze as much money out of patients as possible.
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
Pharmacy Benefit Managers (PBMs) are driving up drug costs for millions of people, employers and the government.
The second in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.